Results 221 to 230 of about 5,464,915 (400)

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

open access: yesMolecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez   +5 more
wiley   +1 more source

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2005
S. Hung   +18 more
semanticscholar   +1 more source

Identification of a Novel Genetic Marker for Risk of Degenerative Rotator Cuff Disease Surgery in the UK Biobank. [PDF]

open access: yesJ Bone Joint Surg Am, 2021
Yanik EL   +7 more
europepmc   +1 more source

Machine learning for identifying liver and pancreas cancers through comprehensive serum glycopeptide spectra analysis: a case‐control study

open access: yesMolecular Oncology, EarlyView.
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima   +6 more
wiley   +1 more source

Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata. [PDF]

open access: yesClin Cosmet Investig Dermatol
Alhetheli G   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy